Sara Harrysson (S Harrysson)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Prognostic Factors

Top Venues

Leukemia & lymphoma

Blood cancer journal

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman, Karin E Smedby
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy. Leukemia & lymphoma 65 (4) (2023)
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman, Karin E Smedby
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy. Leukemia & lymphoma 65 (4) (2023)
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Kristina Sonnevi, Maria Ljungqvist, Birgitta Sander, Mats Jerkeman, Karin E Smedby
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy. Leukemia & lymphoma (2023)
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Tarec C El-Galaly, Birgitta Sander, Kristina Sonnevi, Per-Ola Andersson, Mats Jerkeman, Karin E Smedby
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients. British journal of haematology 198 (2) (2022)
Sara Ekberg, Sara Harrysson, Tomas Jernberg, Karolina Elisabeth Szummer, P-O Andersson, Mats Jerkeman, Karin E Smedby, Sandra Eloranta
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study. Journal of internal medicine 290 (5) (2021)
Kristina Sonnevi, Maria Ljungqvist, Jóel Kristinn Jóelsson, Sara Harrysson, Tove Wästerlid, Per Bernell, Björn Engelbrekt Wahlin
Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience. EJHaem 2 (4) (2021)
Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Bjorn E Wahlin, Per-Ola Andersson, Karin E Smedby
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden. Blood cancer journal 11 (1) (2021)
Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh, Parviz Kokhaei, Jan Vågberg, Johan Schultz, Thomas Olin, Sara Harrysson, Karin E Smedby, Elias Drakos, Georgios Z Rassidakis, Anders Österborg, Mohammad Hojjat-Farsangi, Håkan Mellstedt
ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells. Biomedicines 8 (6) (2020)